Treatment of Liver Ischemia–reperfusion Injury by Limiting Thrombospondin-1/Cd47 Signaling

Surgery - United States
doi 10.1016/j.surg.2008.07.009
Full Text
Abstract

Available in full text

Categories
Surgery
Date
Authors
Publisher

Elsevier BV

Related search

Blocking Thrombospondin-1/Cd47 Signaling Alleviates Deleterious Effects of Aging on Tissue Responses to Ischemia

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2007English

An Injury of the Liver Caused by Ischemia-Reperfusion in Rat Liver.

Folia Pharmacologica Japonica
Pharmacology
1991English

Treatment With Metformin Prevents Myocardial Ischemia-Reperfusion Injury via STEAP4 Signaling Pathway

Anatolian journal of cardiology
Cardiovascular MedicineCardiology
2019English

Induction of Heme Oxygenase-1 Protects Mouse Liver From Apoptotic Ischemia/Reperfusion Injury

Apoptosis : an international journal on programmed cell death
Cell BiologyPharmacologyBiochemistryClinical BiochemistryCancer ResearchPharmaceutical Science
2013English

HO-1–STAT3 Axis in Mouse Liver Ischemia/Reperfusion Injury: Regulation of TLR4 Innate Responses Through PI3K/PTEN Signaling

Journal of Hepatology
Hepatology
2012English

Biliverdin Protects Against Liver Ischemia Reperfusion Injury in Swine

PLoS ONE
Multidisciplinary
2013English

Intestinal Microflora in Rats With Ischemia/Reperfusion Liver Injury

Journal of Zhejiang University SCIENCE
2005English

Factors in the Pathophysiology of the Liver Ischemia-Reperfusion Injury

Journal of Surgical Research
Surgery
2008English

Hepatic Ischemia-Reperfusion Injury: Pathogenesis and Pharmacological Treatment

Advances in Medicine and Medical Research
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy